Literature DB >> 7598995

Bismuth salts and neurotoxicity. A randomised, single-blind and controlled study.

L A Noach1, J L Eekhof, L J Bour, F E Posthumus Meyjes, G N Tytgat, B W Ongerboer de Visser.   

Abstract

The aim of this work was to investigate whether the normal use of colloidal bismuth subcitrate (CBS) and bismuth subnitrate (BSN) exhibits neurotoxic side-effects. A randomised, single-blind controlled study was carried out in 66 patients with H. pylori associated gastritis. Patients were randomised to receive either amoxicillin (control group) for 4 weeks or BSN for 8 weeks or CBS for 8 weeks. Clinical and neurophysiological tests including electroneurography (ENG) and spectral electroencephalography (EEG) were performed before and after therapy. No clinically relevant changes were observed with clinical tests as well as with ENG and spectral EEG recordings within each group and between the groups. It was concluded that the normal use of CBS and BSN does not exhibit clinical neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7598995     DOI: 10.1177/096032719501400405

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  7 in total

Review 1.  Acute renal failure after overdose of colloidal bismuth subcitrate.

Authors:  Nurcan Cengiz; Yasemin Uslu; Faysal Gök; Ali Anarat
Journal:  Pediatr Nephrol       Date:  2005-06-10       Impact factor: 3.714

2.  Bismuth Concentrations in Patients Treated in Real-Life Practice with a Bismuth Subcitrate-Metronidazole-Tetracycline Preparation: The SAPHARY Study.

Authors:  Estelle Guiard; Bénédicte Lelievre; Magali Rouyer; Frank Zerbib; Bertrand Diquet; Francis Mégraud; François Tison; Emmanuelle Bignon; Régis Lassalle; Cécile Droz-Perroteau; Nicholas Moore; Patrick Blin
Journal:  Drug Saf       Date:  2019-08       Impact factor: 5.606

3.  Bismuth coating of non-tunneled haemodialysis catheters reduces bacterial colonization: a randomized controlled trial.

Authors:  Ralf Schindler; Uwe Heemann; Ulrike Haug; Benjamin Stoelck; Aysun Karatas; Cosima Pohle; Reinhold Deppisch; Werner Beck; Markus Hollenbeck
Journal:  Nephrol Dial Transplant       Date:  2010-03-17       Impact factor: 5.992

4.  Comparison of three different regimens against Helicobacter pylori as a first-line treatment: A randomized clinical trial.

Authors:  Ayse Kefeli; Sebahat Basyigit; Abdullah Ozgur Yeniova; Tarık Tayfur Kefeli; Muzaffer Aslan; Ozlem Tanas
Journal:  Bosn J Basic Med Sci       Date:  2016-01-01       Impact factor: 3.363

5.  Role of intestinal microbiota in transformation of bismuth and other metals and metalloids into volatile methyl and hydride derivatives in humans and mice.

Authors:  Klaus Michalke; Annette Schmidt; Britta Huber; Jörg Meyer; Margareta Sulkowski; Alfred V Hirner; Jens Boertz; Frank Mosel; Philip Dammann; Gero Hilken; Hans J Hedrich; Martina Dorsch; Albert W Rettenmeier; Reinhard Hensel
Journal:  Appl Environ Microbiol       Date:  2008-03-31       Impact factor: 4.792

6.  Production of toxic volatile trimethylbismuth by the intestinal microbiota of mice.

Authors:  Britta Huber; Philip Dammann; Christine Krüger; Petra Kirsch; Beatrix Bialek; Roland A Diaz-Bone; Reinhard Hensel
Journal:  J Toxicol       Date:  2011-10-10

7.  Systematic Review and Meta-Analyses Assessment of the Clinical Efficacy of Bismuth Subsalicylate for Prevention and Treatment of Infectious Diarrhea.

Authors:  Jose M Brum; Roger D Gibb; David L Ramsey; Guhan Balan; Bruce R Yacyshyn
Journal:  Dig Dis Sci       Date:  2020-08-08       Impact factor: 3.199

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.